PureTech Health plc (OTCMKTS:PTCHF) Short Interest Update

PureTech Health plc (OTCMKTS:PTCHFGet Rating) was the target of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 3,200 shares, an increase of 77.8% from the April 15th total of 1,800 shares. Based on an average daily volume of 13,600 shares, the days-to-cover ratio is presently 0.2 days.

OTCMKTS:PTCHF opened at $2.19 on Friday. PureTech Health has a twelve month low of $1.97 and a twelve month high of $5.82. The stock has a fifty day simple moving average of $2.51 and a 200-day simple moving average of $3.41.

PureTech Health Company Profile (Get Rating)

PureTech Health plc, a clinical stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and dementia-related psychosis; a hydrogel platform technology to treat obesity and other chronic metabolic diseases; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; a immunomodulation platform to treat chronic and acute inflammatory disorders; therapies for immune-mediated diseases based on a rationally-defined consortia of human microbiome-derived bacteria; and a digital treatments to treat cognitive dysfunction associated with neurology and psychiatry conditions.

Featured Stories

Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.